Roquefort Therapeutics Investor Relations Material
Latest events
H2 2024
29 Apr, 2025
H1 2024
27 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Roquefort Therapeutics PLC
Access all reports
Roquefort Therapeutics PLC is a United Kingdom-based biotechnology company focused on developing novel therapies targeting cancer and autoimmune diseases. The company specializes in discovering and advancing small molecule and RNA-based therapeutics through its proprietary platforms. Its operations span early-stage research, preclinical testing, and strategic collaborations for drug development. Roquefort Therapeutics PLC is headquartered in London, United Kingdom, and its shares are listed on the LSE.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
ROQ
Country
🇬🇧 United Kingdom